Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
229.6 CHF | -0.52% | -3.61% | -6.09% |
Mar. 12 | Roche: AGM approves dividend increase | CF |
Mar. 12 | ROCHE HOLDINGS AG : Sell rating from Deutsche Bank | ZD |
Sales 2024 * | 59.43B 66.95B | Sales 2025 * | 63.06B 71.04B | Capitalization | 184B 208B |
---|---|---|---|---|---|
Net income 2024 * | 12.99B 14.63B | Net income 2025 * | 14.47B 16.3B | EV / Sales 2024 * | 3.32 x |
Net Debt 2024 * | 13.23B 14.9B | Net Debt 2025 * | 7.16B 8.06B | EV / Sales 2025 * | 3.04 x |
P/E ratio 2024 * |
14.1
x | P/E ratio 2025 * |
12.6
x | Employees | 103,605 |
Yield 2024 * |
4.18% | Yield 2025 * |
4.34% | Free-Float | 88.06% |
Latest transcript on Roche Holding AG
1 day | -0.52% | ||
1 week | -3.61% | ||
Current month | -1.01% | ||
1 month | +0.61% | ||
3 months | -6.04% | ||
6 months | -12.15% | ||
Current year | -6.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.03% | 121 M€ | -.--% | - | |
8.46% | 18 M€ | +4.89% | - | |
4.67% | 2 M€ | -.--% | ||
2.85% | 6 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 229.6 | -0.52% | 928,192 |
24-03-15 | 230.8 | -0.69% | 5,852,354 |
24-03-14 | 232.4 | -3.57% | 1,964,137 |
24-03-13 | 241 | -1.53% | 1,862,536 |
24-03-12 | 244.8 | +1.14% | 2,094,425 |
Delayed Quote Swiss Exchange, March 18, 2024 at 12:31 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.09% | 210B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-2.92% | 203B | |
-3.72% | 158B | |
-5.94% | 144B |